LICARI, AMELIA
 Distribuzione geografica
Continente #
NA - Nord America 6.353
EU - Europa 4.514
AS - Asia 3.726
SA - Sud America 638
AF - Africa 42
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.292
Nazione #
US - Stati Uniti d'America 6.259
CN - Cina 1.890
IE - Irlanda 1.413
HK - Hong Kong 965
RU - Federazione Russa 811
BR - Brasile 589
SG - Singapore 563
DE - Germania 500
FI - Finlandia 465
IT - Italia 461
UA - Ucraina 252
GB - Regno Unito 175
SE - Svezia 163
IN - India 71
CA - Canada 66
BE - Belgio 59
FR - Francia 44
VN - Vietnam 42
AT - Austria 40
NL - Olanda 26
TR - Turchia 23
BD - Bangladesh 21
JP - Giappone 21
ES - Italia 19
AR - Argentina 18
MX - Messico 18
PL - Polonia 17
AU - Australia 14
IR - Iran 14
IQ - Iraq 13
ZA - Sudafrica 12
CZ - Repubblica Ceca 11
PH - Filippine 11
UZ - Uzbekistan 11
DK - Danimarca 9
PK - Pakistan 9
EC - Ecuador 8
AZ - Azerbaigian 7
LT - Lituania 7
MU - Mauritius 7
JO - Giordania 6
KR - Corea 6
LA - Repubblica Popolare Democratica del Laos 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
CO - Colombia 5
GR - Grecia 5
LK - Sri Lanka 5
MA - Marocco 5
PT - Portogallo 5
VE - Venezuela 5
CL - Cile 4
EG - Egitto 4
GE - Georgia 4
IL - Israele 4
PE - Perù 4
RO - Romania 4
RS - Serbia 4
SA - Arabia Saudita 4
BO - Bolivia 3
BY - Bielorussia 3
CH - Svizzera 3
CR - Costa Rica 3
ET - Etiopia 3
ID - Indonesia 3
KG - Kirghizistan 3
LV - Lettonia 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TN - Tunisia 3
TW - Taiwan 3
EU - Europa 2
HU - Ungheria 2
KE - Kenya 2
KZ - Kazakistan 2
MT - Malta 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AP - ???statistics.table.value.countryCode.AP??? 1
BM - Bermuda 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
HN - Honduras 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
LU - Lussemburgo 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PY - Paraguay 1
SI - Slovenia 1
TJ - Tagikistan 1
Totale 15.290
Città #
Dublin 1.388
Chandler 1.384
Hong Kong 962
Ashburn 553
Jacksonville 410
Boardman 405
Nanjing 385
Beijing 370
Singapore 281
Princeton 276
Helsinki 273
Lawrence 265
Medford 241
Wilmington 197
Moscow 155
Shanghai 153
Nanchang 149
New York 112
Munich 110
Changsha 109
Ann Arbor 102
Hebei 102
Shenyang 98
Jiaxing 95
Los Angeles 93
The Dalles 90
Milan 79
Tianjin 68
Hangzhou 64
Washington 57
Brussels 55
Pavia 51
Turku 51
Seattle 48
Nuremberg 47
Toronto 46
Rome 45
Woodbridge 43
Fairfield 41
Redwood City 39
São Paulo 39
Dearborn 37
Dallas 32
Norwalk 31
Chicago 28
Dong Ket 28
Pune 27
San Francisco 27
Brooklyn 22
Frankfurt am Main 19
Houston 18
Rio de Janeiro 18
Guangzhou 17
Vienna 17
Brasília 16
Tokyo 16
Cambridge 15
Düsseldorf 15
Belo Horizonte 14
Falkenstein 14
Florence 13
Kunming 13
Los Montesinos 13
Palermo 13
Wuhan 13
London 12
Santa Clara 12
Jinan 11
Turin 11
Vicenza 11
Warsaw 11
Dhaka 10
Shenzhen 10
Zhengzhou 10
Falls Church 9
Gunzenhausen 9
Hyderabad 9
Ningbo 9
Porto Alegre 9
Tashkent 9
Boston 8
Charlotte 8
Des Moines 8
Mumbai 8
Baku 7
Berlin 7
Las Vegas 7
Mainz 7
Olomouc 7
Orange 7
Salvador 7
Taizhou 7
Verona 7
Borås 6
Council Bluffs 6
Curitiba 6
Detroit 6
Hanoi 6
Hefei 6
Johannesburg 6
Totale 10.296
Nome #
Evaluation of the effects of a probiotic supplementation with respect to placebo on intestinal microflora and secretory IgA production, during antibiotic therapy, in children affected by recurrent airway infections and skin symptoms. 146
Impact of passive smoke and/or atopy on adenoid immunoglobulin production in children 104
Bi-allelic genetic variants in the translational GTPases GTPBP1 and GTPBP2 cause a distinct identical neurodevelopmental syndrome 103
Sensitisation and allergy in pediatric age: role in vivo and in vitro tests 102
Probiotics and food allergy 100
Congenital vascular rings: A clinical challenge for the pediatrician. 95
Cross reactivity between recombinant parvalbumin of carp and cod and recombinant grass molecules 94
Il neonato prematuro e di basso peso 93
Adenoids in children: Advances in immunology, diagnosis, and surgery 90
Adenoids during childhood: the facts. 90
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 88
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 88
Il mucocele sfenoidale in età pediatrica 87
Chronic cough in childhood: A systematic review for practical guidance by the Italian Society of Pediatric Allergy and Immunology 82
A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: A three-center, assessor blinded trial 81
Dermatite atopica: patologie respiratorie 80
Efficacy of Grintuss® pediatric syrup in treating cough in children: a randomized, multicenter, double blind, placebo-controlled clinical trial. 80
Efficacy of Bacillu clausii spores in tha prevention of recurrent respiratory infections in children: a pilot study 79
Clinical comparison between previous and new ISAC test kit 78
Adenoids and clinical symptoms: Epidemiology of a cohort of 795 pediatric patients 78
A polycentric, randomized, double blind, parallel-group, placebo-controlled study on Lertal®, a multicomponent nutraceutical, as add-on treatment in children with allergic rhinoconjunctivitis: phase I during active treatment 78
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 78
The 10-day mark is a good way to diagnose not only acute rhinosinusitis but also adenoiditis, as confirmed by endoscopy. 77
Acute isolated sphenoid sinusitis in children. 77
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 77
Emergency Department and Out-of-Hospital Emergency System (112—AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre 77
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 77
Agreements and controversies of national guidelines for bronchiolitis: Results from an Italian survey 77
Adenoid hypetrophy: definition of some risk factors 76
Acalculous Acute Cholecystitis in Previously Healthy Children: General Overview and Analysis of Pediatric Infectious Cases 75
Adenoids during childhood: the facts. 75
Basophil activation test in children with autoimmune chronic spontaneous urticaria: Is it ready for clinical practice? 75
Polmonite 74
Pidotimod may prevent recurrent respiratory infections in children. 74
Asthma endotyping and biomarkers in childhood asthma 74
Eosinophilic gastrointestinal disorders in children: An Italian single-center experience 74
Usefulness of molecular diagnosis 74
Profilo citochinico Th1/Th2 delle cellule mononucleate del tessuto linfatico nasofaringeo e del sangue periferico in bambini atopici e non atopici. 73
Current recommendations and emerging options for the treatment of allergic rhinitis. 73
ATOPIC DERMATITIS: IS THERE A ROLE FOR PROBIOTICS? 73
From IgE to clinical trials of allergic rhinitis 70
PROBIOTICS AND INFLAMMATORY BOWEL DISEASES 70
Atypical erythema annulare centrifugum in a child with celiac disease 70
Chronic urticaria caused by Hymenolepis nana in an adopted girl. 69
Egg allergy: diagnosis and benefit of basophilic activation test 69
Clinical use of basophil activation test in drug, food and hymenoptera venom allergies 69
COVID vaccination and asthma exacerbation: might there be a link? 69
Biological therapies in children and adolescents with severe uncontrolled asthma: A practical review 69
La terapia della tosse 68
Difficult vs. Severe Asthma: Definition and limits of asthma control in the pediatric population 67
Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis 67
Changes in allergen distribution's depending on geographical ares: an ISAC investigation 67
Inflammation of paranasal sinuses:the clinical pattern is age-dependent. 66
Pentraxin 3 In Children Suffering From Allergic Rhinitis 66
Acute Pustular Dermatosis, Following Topical Treatment With Pimecrolimus, in a Child Affected With Atopic and Contact Hand Dermatitis 66
Il bambino con patologia ostruttiva delle alte vie aeree: inquadramento clinico, diagnostico e terapeutico. 65
The role of specific IgE in sensitisation and allergy 65
Il quadro polmonare nella malattia di Niemann-Pick. 64
Sublingual immunotherapy for pediatric allergic rhinitis: The clinical evidence 64
The role of upper airway pathology as a co-morbidity in severe asthma 64
Predicting challenge outcomes in children: role of histamine levels 63
Omalizumab in children. 62
An update on anti-ige therapy in pediatric respiratory diseases 62
Biomarkers of immunotherapy response in patients with allergic rhinitis 62
An update on biological therapies for pediatric allergic diseases 62
Allergen immunotherapy in children and adolescents with respiratory diseases 61
Allergy and asthma in children and adolescents during the COVID outbreak: What we know and how we could prevent allergy and asthma flares 61
Eosinophilic cationic protein (ECP) in the clinical work-up of chronic cough 60
La cute come organo immune. 60
Comparison of total serum and cord IgE in newborns 60
Anxiety and Depression in Adolescents with Severe Asthma and in Their Parents: Preliminary Results after 1 Year of Treatment 60
Severe asthma in children: Current goals and unmet needs 60
Biologic Use in Allergic and Asthmatic Children and Adolescents during the COVID-19 Pandemic 60
Valganciclovir treatment in a 6-month-old infant with asymptomatic congenital cytomegalovirus infection and late hearing loss 59
Acute cough in children and adolescents: A systematic review and a practical algorithm by the Italian Society of Pediatric Allergy and Immunology 59
Allergy and covid-19 59
COVID-19 and autoimmune diseases: is there a connection? 58
Cord and blood levels of newborn IgE: Correlation, role and influence of maternal IgE 58
Omalizumab for the treatment of chronic idiopathic/spontaneous urticaria in children 58
Clinical and Epidemiological Features of Pediatric Patients with COVID-19 in a Tertiary Pediatric Hospital 57
Diagnosi di Patologie Respiratorie 57
Probiotics and respiratory diseases. 57
The comparison of basophil activation test with other diagnostic tests to diagnose milk-allergy in children 57
Asthma control in children and adolescents: a study in clinical practice 57
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 57
I rapporti fra le alte e basse vie respiratorie 56
Interleukin-9 in patients with cutaneous diseases 56
Gli antiistaminici 56
Anxiety/depression changes are associated with improved asthma control perception in asthmatic adolescents after adequate management 56
Kinetic and Angiogenic Activity of Circulating Endothelial Colony Forming Cells in Patients with Infantile Haemangioma Receiving Propranolol 56
Behavioral issues and quality of life in children with eosinophilic esophagitis 56
SARS-CoV-2 infection in pediatric population 56
Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre 56
Eosinophilic gastrointestinal disorders in children and adolescents: A single-center experience 55
Malattie dell'apparato respiratorio 55
Allergic rhinitis in apparently healthy subjects 55
Adenoidal immune response in the context of inflammation and allergy 55
Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents 55
Novel therapeutic approaches targeting endotypes of severe airway disease 55
46, XY Disorders of Sexual Development: a case report and its theoretical framework 54
Totale 7.008
Categoria #
all - tutte 90.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.225


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021873 57 113 47 95 41 105 26 148 24 103 67 47
2021/20221.258 15 6 43 14 26 100 16 52 93 46 168 679
2022/20233.940 460 283 61 339 310 383 6 187 1.673 28 161 49
2023/20241.959 259 339 110 115 169 482 115 96 10 96 77 91
2024/20255.270 106 498 164 167 134 237 391 287 1.287 270 613 1.116
Totale 15.679